Dampening the fire to prevent surgery- and chemotherapy-induced metastasis
Esra Güç and Jeffrey W. Pollard
MRC Centre for Reproductive Health, Queen’s Medical Research Institute, The University of Edinburgh, Scotland, United Kingdom.
Address correspondence to: Jeffrey W. Pollard, MRC Centre for Reproductive Health, Queen’s Medical Research Institute, Edinburgh BioQuarter, 47 Little France Crescent, EH16 4TJ, Edinburgh, Scotland, United Kingdom. Phone: 44.0.1312426231; Email: Jeff.Pollard@ed.ac.uk.
Find articles by Güç, E. in: JCI | PubMed | Google Scholar
MRC Centre for Reproductive Health, Queen’s Medical Research Institute, The University of Edinburgh, Scotland, United Kingdom.
Address correspondence to: Jeffrey W. Pollard, MRC Centre for Reproductive Health, Queen’s Medical Research Institute, Edinburgh BioQuarter, 47 Little France Crescent, EH16 4TJ, Edinburgh, Scotland, United Kingdom. Phone: 44.0.1312426231; Email: Jeff.Pollard@ed.ac.uk.
Find articles by Pollard, J. in: JCI | PubMed | Google Scholar
First published June 17, 2019 - More info
J Clin Invest. 2019;129(7):2663–2665. https://doi.org/10.1172/JCI129705.
© 2019 American Society for Clinical Investigation
In this issue of the JCI, Panigrahy et al. demonstrate that preoperative administration of the antiinflammatory drug ketorolac or specialized proresolving mediators (SPM) called resolvins increases disease-free survival rates and prevents metastasis after surgery and chemotherapy in mouse models of cancer. The antitumor response was partially mediated by tumor-specific T cell immunity and immunological memory.
- Purchase this article
- $10
- Purchasing this article will give you full access for the calendar year.
- Purchase Site Pass
- $25
- This will give you access to every article on the site for 24 hours.
- Online subscription
- $95
- Individual online subscriptions give you full online access for the calendar year.
- Individual online subscriptions ordered from September 1st on will receive access for the remainder of current year as well as for the full following year subscription term.
- Print subscription
- $830
- Individual print subscriptions give you the print journal and full online access for the year.
- JCI This Month subscription
- $125
- JCI This Month is a 16- to 20-page overview of the articles published each month
- Subscribing to JCI This Month also gives subscribers full online access for the calendar year.
- *Price outside U.S. and Canada: $225.
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)